高级检索
当前位置: 首页 > 详情页

The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Gynecology, The First People’s Hospital of Yunnan Province, Kunming, China [2]The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China [3]Department of Gynecology, The People’s Hospital of Hezhou, Hezhou, China
出处:
ISSN:

关键词: Polycystic ovary syndrome hyperandrogenemia insulin resistance abnormal blood lipids

摘要:
ObjectiveThis study aimed to investigate the impact of serum androgen levels on metabolic profiles in patients with polycystic ovary syndrome (PCOS).MethodsWe included 216 patients with PCOS and 216 healthy individuals selected as the control group. According to the measured serum androgen levels, patients with PCOS were divided into the hyperandrogenism group and non-hyperandrogenism group. Clinical metabolic indicators were assessed and compared between the two groups. Additionally, we assessed the correlation between androgen levels and clinical metabolic indicators.ResultsThe body mass index, waist-to-hip ratio, mF-G score, and acne score, as well as T, LH, LSH/FSH, FPG, Cr, UA, TG, TC, and LDL-C levels were significantly higher in the PCOS group than in the control group. The incidence of hyperandrogenism and clinical hyperandrogenism in the PCOS group was significantly higher than that in the control group. Regarding clinical hyperandrogenism, hirsutism, acne, and acanthosis nigricans were significantly more common in the PCOS group than in the control group. Serum androgen levels were significantly correlated with the mF-G score, acne score, FSH, glucose concentration at 30 min, glucose concentration at 60 min, glucose concentration at 120 min, FINS, N120, HOMA-IR, HbA1c, AUCG, UA, TG, and hHDL-Clevels.ConclusionElevated serum androgen levels are commonly observed in patients with PCOS and are associated with multiple metabolic abnormalities. Therefore, it is recommended to regularly monitor glucose and lipid metabolism-related indicators in patients with PCOS who have elevated androgen levels.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 内分泌学与代谢 4 区 妇产科学
JCR分区:
出版当年[2023]版:
Q2 OBSTETRICS & GYNECOLOGY Q3 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q2 OBSTETRICS & GYNECOLOGY Q3 ENDOCRINOLOGY & METABOLISM

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Department of Gynecology, The First People’s Hospital of Yunnan Province, Kunming, China [2]The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Gynecology, The First People’s Hospital of Yunnan Province, Kunming, China [2]The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China [*1]Gynecology Department, The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, No. 157 Jinbi Road, Kunming, 650032 Yunnan, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82490 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号